Skip to main content
Retour
Watch Compare

SBC Medical Group Holdings Inc

Qualité des données : 100%
Également cotée sous SBCWW Nasdaq
SBC
Nasdaq Services Health Services
4,15 €
▼ 0,02 € (-0,48%)
Cap. Boursière: 422,62 M
Prix
4,12 €
Cap. Boursière
422,62 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

ROE of 20,70% indicates high profitability
Net margin of 29,37% shows strong profitability
Debt/Equity of 0,09 — conservative balance sheet
Generating 23,27 M in free cash flow
P/E of 8,29 — trading at a low valuation
Capital efficient — spends only 0,81% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-15,48%
Earnings (1Y)9,38%
FCF Growth (3Y)N/A

Qualité

Return on Equity
20,70%
Au-dessus de la moyenne du secteur (-15,95%)
ROIC15,80%
Net Margin29,37%
Op. Margin38,87%

Sécurité

Debt / Equity
0,09
En dessous de la moyenne du secteur (0,39)
Current Ratio5,10
Interest Coverage455,26

Valorisation

PE (TTM)
8,29
Au-dessus de la moyenne du secteur (-1,17)
P/B Ratio1,70
EV/EBITDA4,51
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E 8,3 -1,2
P/B 1,7 1,4
ROE % 20,7 -16,0
Net Margin % 29,4 -19,4
Rev Growth 5Y % — 3,8
D/E 0,1 0,4

ETFs Holding This Stock

INDE logo INDE Matthews India Active ETF INDE
0,60% weight
AVEE logo AVEE Avantis Emerging Markets Small Cap Equity ETF
0,01% weight
FLQS FLQS
0,00% weight
AVXC logo AVXC Avantis Emerging Markets ex-China Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -15,48% Revenue Growth (3Y) N/A
Earnings Growth (1Y) 9,38% Earnings Growth (3Y) 860,36%
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 173,61 M Net Income (TTM) 50,99 M
ROE 20,70% ROA 16,02%
Gross Margin 73,32% Operating Margin 38,87%
Net Margin 29,37% Free Cash Flow (TTM) 23,27 M
ROIC 15,80% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,09 Current Ratio 5,10
Interest Coverage 455,26 Asset Turnover 0,55
Working Capital 182,62 M Tangible Book Value 219,76 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 8,29 Forward P/E N/A
P/B Ratio 1,70 P/S Ratio 2,43
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 4,51 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 5,51%
Market Cap 422,62 M Enterprise Value 316,31 M
Per Share
EPS (Diluted TTM) 0,50 Revenue / Share 1,69
FCF / Share 0,23 OCF / Share 0,24
EPS CAGR (1Y) 4,17% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,81% FCF Conversion 45,64%
SBC-Adj. FCF 23,27 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023
Revenue 173,61 M 205,42 M — —
Net Income 50,99 M 46,61 M 552 813,0 339 767,0
EPS (Diluted) 0,50 0,48 — —
Gross Profit 127,28 M 156,05 M — —
Operating Income 67,49 M 70,30 M -543 695,0 -1,77 M
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses 59,80 M 57,67 M — —
D&A 2,68 M 3,80 M — —
Interest Expense 148 238,0 28 300,0 — —
Income Tax 31,02 M 26,77 M 248 508,0 528 809,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023
Total Assets 380,45 M 266,08 M 119,94 M 21,25 M
Total Liabilities 117,14 M 71,06 M 4,59 M 6,63 M
Shareholders' Equity 248,28 M 195,11 M -3,36 M -5,99 M
Total Debt 42,83 M 6,60 M — —
Cash & Equivalents 163,77 M 125,04 M 485 564,0 —
Current Assets 231,22 M 184,45 M 722 189,0 394 543,0
Current Liabilities 61,12 M 61,19 M 566 012,0 2,61 M